The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
Open accessAbstract
BACKGROUND: Amyloid protein precursor (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2) mutations cause autosomal dominant forms of early-onset Alzheimer disease (AD-EOAD). Although these genes were identified in the 1990s, variant classification remains a challenge, highlighting the need to colligate mutations from large series. METHODS AND FINDINGS: We report here a novel update (2012-2016) of the genetic screening of the large AD-EOAD series ascertained across 28 French hospitals from 1993 onwards, bringing the total number of families with identified mutations to n = 170. Families were included when at least two first-degree relatives suffered from early-onset Alzheimer disease (EOAD) with an age of onset (AOO) ≤65 y in two generations. Furthermore, we also screened 129 sporadic cases of Alzheimer disease with an AOO below age 51 (44% males, mean AOO = 45 ± 2 y). APP, PSEN1, or PSEN2 mutations were identified in 53 novel AD-EOAD families. Of the 129 sporadic cases screened, 17 carried a PSEN1 mutation and 1 carried an APP duplication (13%). Parental DNA was available for 10 sporadic mutation carriers, allowing us to show that the mutation had occurred de novo in each case. Thirteen mutations (12 in PSEN1 and 1 in PSEN2) identified either in familial or in sporadic cases were previously unreported. Of the 53 mutation carriers with available cerebrospinal fluid (CSF) biomarkers, 46 (87%) had all three CSF biomarkers-total tau protein (Tau), phospho-tau protein (P-Tau), and amyloid β (Aβ)42-in abnormal ranges. No mutation carrier had the three biomarkers in normal ranges. One limitation of this study is the absence of functional assessment of the possibly and probably pathogenic variants, which should help their classification. CONCLUSIONS: Our findings suggest that a nonnegligible fraction of PSEN1 mutations occurs de novo, which is of high importance for genetic counseling, as PSEN1 mutational screening is currently performed in familial cases only. Among the 90 distinct mutations found in the whole sample of families and isolated cases, definite pathogenicity is currently established for only 77%, emphasizing the need to pursue the effort to classify variants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in PS1 and PS2 primarily alter APP γ-cleavage, thereby resulting in a decreased Aβ40/42 ratio.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [37]
In the citing paper
“Although causal variants in these genes are typically thought to be inherited in an autosomal dominant fashion, de novo variants in APP, PSEN1, and PSEN2 have also been identified by sequencing in sporadic cases of EOAD that occur with no family history of disease [158, 159].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [158]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Rovelet‐Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin‐Njock, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,284
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075
A framework for the interpretation of de novo mutation in human disease
Samocha, K. E., Robinson, E. B., Sanders, S. J., Stevens, C., Sabo, A., McGrath, L. M., Kosmicki, J. A., Rehnström, K., Mallick, S., Kirby, A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3050 · Cited by 979
A Familial Alzheimer's Disease Locus on Chromosome 1
Levy‐Lahad, E., Wijsman, E. M., Nemens, E. J., Anderson, L., Goddard, K. A. B., Weber, J. L., Bird, T. D., & Schellenberg, G. D. (1995) · Science · doi:10.1126/science.7638621 · Cited by 832
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 614
Klotz, S., & Gelpí, E. (2021) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-021-00848-4 · Cited by 4
Towards mechanistic models of mutational effects: Deep learning on Alzheimer’s Aβ peptide
Wang, B., Razavi, S., & Gamazon, E. R. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.03.051 · Cited by 5
Dementia and cognitive decline
Huq, A. J., Eratne, D., & Velakoulis, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99417-0.00006-9 · Cited by 4
Lysosomal enzyme tripeptidyl peptidase 1 plays a role in degradation of beta amyloid fibrilsPreprint
Cruz, D. L., El-Banna, M., Majumdar, A., Sleat, D. E., Muldowney, M., Lobel, P., & Maxfield, F. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/639682 · Cited by 4
Bhansali, P. R., Sonkusare, S. M., Savale, S. S., Wijayasinghe, Y. S., Liao, Y., Sloan, D. C., Chaturbhuj, G. U., & Muntean, B. S. (2025) · Frontiers in Chemistry · doi:10.3389/fchem.2025.1642190 · Cited by 3
Alam, P., Sharma, P. K., Kirtipal, N., & Akhtar, A. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11388-z · Cited by 3
Li, M., Zhao, Y., Wang, Y., He, R., Zhao, G., Wang, X., Xu, Y., Cao, H., Liu, H., Mao, C., et al. (2025) · Movement Disorders · doi:10.1002/mds.70106 · Cited by 3
Transcriptional Profiling of Hippocampus Identifies Network Alterations in Alzheimer’s Disease
Quarato, V., D’Antona, S., Battista, P., Zupo, R., Sardone, R., Castiglioni, I., Porro, D., Frasca, M., & Cava, C. (2022) · Applied Sciences · doi:10.3390/app12105035 · Cited by 3
Ge, S., Cai, M., & Pei, G. (2022) · Cell Discovery · doi:10.1038/s41421-022-00444-9 · Cited by 3
Alves, L. B., Ordoñez, W. O. C., & Giuliatti, S. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2112079 · Cited by 3
The Role of Inflammasomes in the Pathogenesis of Neurodegenerative Diseases
Shevchuk, D. V., Abramova, A. A., & Zakharova, M. N. (2022) · Neurochemical Journal · doi:10.1134/s1819712422030114 · Cited by 3
Screening for Genetic Mutations Associated with Early-Onset Alzheimer’s Disease in Han Chinese
Liu, C., Cong, L., Zhu, M., Wang, Y., Tang, S. H., Han, X., Zhang, Q., Tian, N., Liu, K., Liang, X., et al. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666221028112915 · Cited by 3
Leveraging Plasma Membrane Repair Therapeutics for Treating Neurodegenerative Diseases
Bulgart, H. R., Goncalves, I., & Weisleder, N. L. (2023) · Cells · doi:10.3390/cells12121660 · Cited by 3
Theron, D., Hopkins, L. N., Sutherland, H. G. E., Griffiths, L. R., & Fernandez, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713480 · Cited by 4
Sun, J., Xi, L., Zhang, D., Gao, F., Wang, L., & Yang, G. (2023) · Scientific Reports · doi:10.1038/s41598-023-46252-3 · Cited by 3
Pharmacogenomic Approaches in Alzheimer's Disease: A Comprehensive Review
Bhat, R., Varshini, V., Himasvi, H., & Shabaraya, R. (2023) · International Journal of Pharmaceutical and Phytopharmacological Research · doi:10.51847/qdmsgl63u7 · Cited by 3
Computational approaches for identifying disease-causing mutations in proteins
Pandey, M., Shah, S. K., & Gromiha, M. M. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.11.007 · Cited by 3
Drug repurposing for neurodegenerative diseases
Shukla, H., John, D., Banerjee, S., & Tiwari, A. K. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.035 · Cited by 3
O’Connor, A., Ryan, N. S., Belder, C. R. S., Lynch, D. S., Lahiri, N., Houlden, H., Rohrer, J. D., Fox, N. C., & O’Dowd, S. (2024) · Practical Neurology · doi:10.1136/pn-2024-004241 · Cited by 4
Shibasaki, Y., Maeda, N., Oshimi, C., Shirakawa, Y., & Saito, M. (2021) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/5.0048559 · Cited by 3
Sahu, S., Dholaniya, P. S., & Rani, T. S. (2022) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-021-00349-9 · Cited by 3
Stratégie diagnostique devant des troubles cognitifs majeurs du sujet jeune
Wallon, D. (2019) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2019.02.001 · Cited by 3
Self-citationMixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation
Libard, S., Giedraitis, V., Kilander, L., Ingelsson, M., & Alafuzoff, I. I. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220655 · Cited by 3
He, S., Zhou, Z., Zhang, J., Wang, Y., Liu, Z., Hao, X., Wang, X., Ye, X., Zhao, Y., & Wang, R. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1797 · Cited by 2
He, B., Ospina-Lopera, P., Espinosa, A. C., Becerra, J. C., Osorio, L., Alzate, D., Álvarez, S., Grazia, A., Teipel, S. J., Malotaux, V., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.71052 · Cited by 2
Silva-Martínez, G. A., Cervantes‐Montelongo, J. A., Tristán-Flores, F. E., & de la Rocha, C. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1716675 · Cited by 2
Zhai, Y., Nevian, T., Finn, D. P., & Kwakowsky, A. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00025-0 · Cited by 2
Amyloid-β clearance: an astrocytic perspective
Li, J., Lv, Z., Chen, X. P., Fu, F., Yang, K., Lai, G., Wu, H., & Xie, G. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1812081 · Cited by 3
Rejili, M., Al‐kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Jabir, M., Shokr, M. M., & Batiha, G. E. (2026) · Purinergic Signalling · doi:10.1007/s11302-026-10160-8 · Cited by 2
Vitamin D in Alzheimer's disease: Neuroinflammatory, metabolic, and clinical implications
Kashif, M., Ho, M.-H., Pandurangan, A. K., Waseem, M., Majumder, D., & Chou, S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261460850 · Cited by 4
Aran, K. R. (2020) · International Journal of Biochemistry & Physiology · doi:10.23880/ijbp-16000185 · Cited by 2
AmazonForest: In Silico Metaprediction of Pathogenic Variants
Palheta, H. G. A., Gonçalves, W. G. E., Brito, L. M., dos Santos, A. R., Matsumoto, M. D. R., Ribeiro‐dos‐Santos, Â., & de Araújo, G. S. (2022) · Biology · doi:10.3390/biology11040538 · Cited by 1
Reyes-Domínguez, Y. A., Figuera, L. E., & Brambila‐Tapia, A. J. L. (2023) · Brain Sciences · doi:10.3390/brainsci13030501 · Cited by 2
Epidemiology of Alzheimer’s disease in the Odesa region
Хубетова, И. В., Voloshchuk, D. A., Kosenko, K., & Vorokhta, Y. M. (2023) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2023.2.270277 · Cited by 2
Shpilyukova, Y. A., Protopopova, A. O., Abramycheva, N. Y., Fedotova, E. Y., & Illarioshkin, S. N. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-2-63-67 · Cited by 2
Yellapu, N. K., Pei, D., Nissen, E., Thompson, J. A., & Koestler, D. C. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.06.003 · Cited by 2
Linking copper and neurotoxic activities to the CNS
Santos, G., Ávila-Rodriguez, M., Rubio, É. P., Galembeck, E., & Borges, J. M. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89835-5.00035-1 · Cited by 2
CD2AP in Alzheimer's disease: Key mechanisms and therapeutic potential
Wang, Y., & Zhang, Y.-W. (2025) · Brain medicine : · doi:10.61373/bm025i.0026 · Cited by 2
Leaf miRNAs of Withania somnifera Negatively Regulate the Aging-Associated Genes in C. elegans
Yadav, S., Gupta, R. K., Kumar, S., Rizvi, A., Tyagi, D., Satish, A., Verma, D., Vishwakarma, A., & Saxena, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04995-2 · Cited by 3
AlSaihati, H., Alazabi, N. I., Bakeer, R. M., Abol-Fetouh, G. M., Ahmed-Farid, O. A.-H., Alshedi, A. F., & Alsabeelah, N. F. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01663-1 · Cited by 2
Probable Novel PSEN1 Gln222Leu Mutation in a Chinese Family with Early-Onset Alzheimer's Disease
Wang, H., Sun, R., Shi, Y., Xia, M., Zhao, J., Yang, M., Ma, L., Sun, Y., Li, G., Zhang, H., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190806161342 · Cited by 2
Связь матричных процессов I и II рода: амилоиды и стабильность генома
Andreychuk, Y. V., Zadorsky, S. P., Zhuk, A. S., Stepchenkova, E. I., & Inge-Vechtomov, S. G. (2020) · Molecular Biology · doi:10.31857/s002689842005002x · Cited by 2
Enrichment of novel Tau isoform with altered biochemical properties in Alzheimer’s disease
Ong, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371359 · Cited by 2
Posterior cortical atrophy: a single case cognitive and radiological follow-up
Esteves, S., Romero, D. A. R., Torralva, T., Cuitiño, M. M., Herndon, S., Couto, B., Ibáñez, A. M., Manes, F. F., & Roca, M. (2018) · Neurocase · doi:10.1080/13554794.2017.1421667 · Cited by 2
Regulation of Caenorhabditis Elegans model in Alzheimer’s Disease
Jing, Y. (2020) · E3S Web of Conferences · doi:10.1051/e3sconf/202018503043 · Cited by 2
Alzheimer’s Disease—Molecular Defect, Public Perceptions and Stigma in South Africa
Maduna, T., & Loos, B. (2021) · Springer eBooks · doi:10.1007/978-981-16-2546-6_4 · Cited by 4
Catania, M., Marti, A., Rossi, G., Fioretti, A., Boiocchi, C., Ricci, M., Gasparini, F., Beltrami, D., Crepaldi, V., Redaelli, V., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.01.008 · Cited by 2
Absence of an Association between Macular Degeneration and Young-Onset Dementia
Kuang, T.-M. T., Xirasagar, S., Lee, W.-Y., Cheng, Y., Kuo, N., & Lin, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020291 · Cited by 2
Altuna, M., Larumbe, R., Zelaya, M. V., Moreno, S., García-Solaesa, V., Mendióroz, M., Ramos, M. A., & Erro, M. E. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11125-8 · Cited by 2
Age of onset predicted by Aβ profiling in a novel PSEN1 (I180F) mutation
Robbie, L., Fernández, S. G., Montoya, L., Sagare, A. P., Barrera, L., Sheikh‐Bahaei, N., Gutiérrez, L. C., & Ringman, J. M. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137591 · Cited by 2
Ronchi, N. R., Castro, M. A. A., Coutinho, A. M., Lucato, L. T., Silva, G. D., Brucki, S. M. D., Kok, F., Trés, E. S., Nóbrega, P. R., Freua, F., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200280 · Cited by 2
Stoychev, K., Stoimenova-Popova, M. Y., Chumpalova, P. G., Ilieva, L., Swamad, M., & Kamburova-Martinova, Z. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00857 · Cited by 2
[18F] FBB cortical uptake is not related to the age of onset of Alzheimer’s disease
Chiaravalloti, A., Barbagallo, G., Castellano, A. E., Ricci, M., Ciccariello, G., Ursini, F., D’Ascenzo, N., Xie, Q., & Schillaci, O. (2019) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001131 · Cited by 2
Lu, J., Sun, Y., Yen, T., Zuo, C., & Wang, J. (2021) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000003674 · Cited by 2
Stefanovski, L., Meier, J. M., Pai, R. K., Triebkorn, P., Lett, T. A. P., Martin, L., Bülau, K., Hofmann‐Apitius, M., Solodkin, A., McIntosh, A. R., et al. (2020) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/4t5qa · Cited by 2
Bayesian Network Modelling for the Clinical Diagnosis of Alzheimer’s DiseasePreprint
Cliere, A.-R. B. S., & Fenton, N. (2024) · medRxiv · doi:10.1101/2023.12.30.23300452 · Cited by 4
A microglia clonal inflammatory disorder in Alzheimer’s DiseasePreprint
Vicario, R., Fragkogianni, S., Weber, L., Lazarov, T., Hu, Y., Hayashi, S. Y., Craddock, B. P., Socci, N. D., Alberdi, A., Baako, A., et al. (2024) · eLife · doi:10.7554/elife.96519.2 · Cited by 2
Generation of sophisticated Alzheimer’s disease mouse models and research advances utilizing them
Hashimoto, S., & Saido, T. C. (2023) · Translational and Regulatory Sciences · doi:10.33611/trs.2023-003 · Cited by 1
Promising Prospects for Human Cerebral Organoids to Advance Alzheimer's Disease Research
López, V., Rosca, A., Liste, I., Mateos-Martínez, P., Coronel, R., González-Sastre, R., Martín-Benito, S., & López, V. (2023) · Progress in Neurobiology · doi:10.60124/j.pneuro.2023.20.05 · Cited by 1
Sivanesan, S., Howell, M. D., Kaushik, V., Rajadas, J., Pari, S. S., & Goyal, P. (2024) · Current Alzheimer Research · doi:10.2174/0115672050324909240823104209 · Cited by 1
The genetic face of brain diseases
Shehryar, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00012-x · Cited by 1
Genetically Engineered Mouse Models for Alzheimer Disease and Frontotemporal Dementia
Chiu, Y., Xia, S., Qiao, H., & Zhao, Z. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.11.006 · Cited by 3
López, S. F., Ferrero, R., Blom-Dahl, J., Alonso-Bernáldez, M., González, A. S. T., Pérez-Solero, G., & Tenorio, J. A. (2025) · Genes · doi:10.3390/genes16040377 · Cited by 1
Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
Мазеркина, И. А. (2025) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2025-13-1-7-19 · Cited by 1
Mainali, N., Balasubramaniam, M., Pahal, S., Griffin, W. S. T., Reis, R. J. S., & Ayyadevara, S. (2025) · Basic Research in Cardiology · doi:10.1007/s00395-025-01109-w · Cited by 2
Valdez-Gaxiola, C. A., Rosales-Leycegui, F., Gaxiola-Rubio, A., Dumois‐Petersen, S., Gallegos‐Arreola, M. P., Ringman, J. M., & Figuera, L. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167929 · Cited by 1
Genetic testing of common and rare variants in dementia patients from a memory clinic
de Rojas, I., Hulsman, M., Tesi, N., van Spaendonk, R. M. L., van der Schaar, J., Dijkstra, J. I. R., van der Flier, W. M., van Ruissen, F., Jansen, P. R., Reinders, M. J. T., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01854-z · Cited by 1
Neurodegenerative Hereditary Diseases
Uher, T. (2025) · Springer eBooks · doi:10.1007/978-3-031-98945-2_8 · Cited by 1
Chande, K., Nirmal, R., Varpe, N., Doke, R. R., Vinchurkar, K., & Singh, S. K. (2025) · 3 Biotech · doi:10.1007/s13205-025-04527-8 · Cited by 1
Is the Era of One-Size-Fits-All Alzheimer’s Treatment Officially Over?
Verma, S., Kumari, K., Kesharwani, P., Verma, K., Dwivedi, J., Paliwal, S., & Sharma, S. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02445-1 · Cited by 1
Polyphenol diet and exercise as neuroprotective factors in a Drosophila model of Alzheimer's disease
Morgan, M., Rodriguez, Z. L., & Hartman, R. E. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70106 · Cited by 1
Exploring cannabinoid modulation on autophagy mechanisms in Alzheimer’s disease: a review
Ntsapi, C., Weyers, M., Chinheya, R. M., Jim, T., & Matsabisa, M. G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1748368 · Cited by 2
Mechanisms to medicines: navigating drug repurposing strategies in Alzheimer’s disease
Khan, S. A., Raza, K., Tiwari, P., El‐Tanani, M., Rabbani, S. A., & Parvez, S. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1676065 · Cited by 1
Farkas, S., Jasper, V., Nyers-Marosi, K., Petrovai, B., Szabó, A., Kvak, E., Sólyomvári, C., Varga, R., Kormos, V., Makkai, G., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115684 · Cited by 1
Shahnaee, A., Liu, C. S., Ngo, T., Palmer, C. R., Ziomek, D., Park, C. S., Tan, V. P., Jimenez, N. A., & Chun, J. J. M. (2026) · Communications Biology · doi:10.1038/s42003-026-09759-9 · Cited by 1
APP E590D mutation increases generation of Aβ and Aη peptides and exacerbates tauopathy
Liu, T., Wetzel, L., Roy, D., Zhang, K., Zhu, Z., Kumaraguru, P., Gorthi, V., Jeon, H., Woo, J. A., & Kang, D. E. (2026) · npj Dementia · doi:10.1038/s44400-026-00069-9 · Cited by 1
Zhou, J., & Chen, M. (2026) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad3020019 · Cited by 1
Genetic Modulators of Disease Penetrance
Kang, Y., & Drivas, T. G. (2026) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-103123-094547 · Cited by 1
Advances in the treatment of Alzheimer’s disease
Goceroglu, R. T., & Hacımüftüoğlu, A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1819165 · Cited by 1
Quenez, O., Schramm, C., Cassinari, K., Nicolas, A., Groeneveld, J., Huguet, G., Grenier‐Boley, B., Hulsman, M., Walters, G. B., de Rojas, I., et al. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.07.013 · Cited by 1
Self-citation1.4 Neuropathologie der Demenzen
(2005) · Thieme eBooks · doi:10.1055/b-0034-22397 · Cited by 1
Hartantyo, R. Y., Hidayat, M. R. M., Azzam, A. B., & Mulyati, M. (2020) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci005203202003 · Cited by 1
Genetic analysis of Vietnamese patients with early-onset Alzheimer's disease
Tong, T. M., Dao, T. T. H., Doan, L. P., Nguyen, D., Nguyen, Q. T., Do, T. T., Truong, K. D., Phan, M., Nguyen, H., Tran, T. C., et al. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1870974 · Cited by 1
A New Presenilin-1 Missense Variant Associated With a Progressive Supranuclear Palsy-like Phenotype
Thomas, Q., Nambot, S., Béjot, Y., Philippe, C., Faivre, L. O., Duffourd, Y., Thauvin‐Robinet, C., & Dupont, G. (2022) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000503 · Cited by 1
Relationship between Type I and Type II Template Processes: Amyloids and Genome Stability
Andreychuk, Y. V., Zadorsky, S. P., Zhuk, A. S., Stepchenkova, E. I., & Inge-Vechtomov, S. G. (2020) · Molecular Biology · doi:10.1134/s0026893320050027 · Cited by 1
Early-onset familial Alzheimer’s disease with spastic paraparesis associated with PSEN1 gene
Rudenskaya, G. E., Petukhova, M. S., Забненкова, В. В., Cherevatova, T., & Рыжкова, О. П. (2023) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2023123111120 · Cited by 1
Epigenetics of Alzheimer’s Disease: Past, Present and Future
Adiga, D., Eswaran, S., Sriharikrishnaa, S., Khan, N. G., Kabekkodu, S. P., & Kumar, D. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010005 · Cited by 1
Potential Stem Cell Treatment for Alzheimer’s Disease with Possible Applications of Lithium Therapy
Caputo, T. J., Inayat, M. S., & Gallicchio, V. S. (2024) · Journal of Clinical and Laboratory Medicine · doi:10.16966/2572-9578.142 · Cited by 1
Biomarkers used in Alzheimer's disease diagnosis
Mishra, S. K., Singh, R., Chang, H., Obaid, A. A., & Singh, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00013-6 · Cited by 1
Diomede, L., Conz, A., Mosconi, M., Stoilova, T., Paloni, M., Salvalaglio, M., Cagnotto, A., Colombo, L., Catania, M., Fede, G. D., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107563 · Cited by 1
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide productionPreprint
Arafi, P., Devkota, S., Williams, E. M., Maesako, M., & Wolfe, M. S. (2024) · eLife · doi:10.7554/elife.102274.3 · Cited by 8
The Neuroprotective Effects of GLP-1 Analogues on Alzheimer's Disease – A Literature Review
Ulicka, W., Dudek, P., Łuczak, K., Chudzikowski, M., Pawlik, A., Pięta, J., Tabeau, A., Sitarek, H., Prus, J., & Prokopiuk, A. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.80.59398 · Cited by 1
Fuentes, M., Schipke, C. G., Freiesleben, S. D., Klostermann, A., & Peters, O. (2021) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acab070 · Cited by 2
Spastic Paraplegia and Cognitive Impairment Due to a De Novo Pathogenic Variant in Presenilin‐1
Muñoz, E., Jodar, M., Guerrero, J., Compta, Y., Perissinotti, A., Álvarez‐Mora, M. I., Falgàs, N., Rodríguez‐Revenga, L., & Sánchez‐Valle, R. (2022) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13588 · Cited by 1
Lin, K., Hsieh, K., Jiang, X., & Kim, Y. (2023) · PubMed Central · Cited by 2
Two Novel PDE11A Genetic Variants Increase Tau Phosphorylations in Early-onset Alzheimer's DiseasePreprint
Qin, W., Zhou, A., Zuo, X., Jia, L., Wei, C., Tang, Y., Wang, F., Li, F., Wang, Q., Li, Y., et al. (2020) · doi:10.21203/rs.3.rs-36875/v1 · Cited by 1
Shafi, V., & Siddiqui, I. (2024) · Research Square · doi:10.21203/rs.3.rs-4408464/v1 · Cited by 1
A microglia clonal inflammatory disorder in Alzheimer’s DiseasePreprint
Vicario, R., Fragkogianni, S., Weber, L., Lazarov, T., Hu, Y., Hayashi, S. Y., Craddock, B. P., Socci, N. D., Alberdi, A., Baako, A., et al. (2024) · eLife · doi:10.7554/elife.96519.1 · Cited by 1
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide productionPreprint
Arafi, P., Devkota, S., Maesako, M., & Wolfe, M. S. (2024) · eLife · doi:10.7554/elife.102274.1 · Cited by 1
Metadata
- Authors
- Lanoiselée, H.-M., Nicolas, G., Wallon, D., Rovelet-Lecrux, A., Lacour, M., Rousseau, S., Richard, A.-C., Pasquier, F., Rollin-Sillaire, A., Martinaud, O., Quillard-Muraine, M., de la Sayette, V., Boutoleau-Bretonniere, C., Etcharry-Bouyx, F., Chauviré, V., Sarazin, M., le Ber, I., Epelbaum, S., Jonveaux, T., Rouaud, O., Ceccaldi, M., Félician, O., Godefroy, O., Formaglio, M., Croisile, B., Auriacombe, S., Chamard, L., Vincent, J.-L., Sauvée, M., Marelli-Tosi, C., Gabelle, A., Ozsancak, C., Pariente, J., Paquet, C., Hannequin, D., Campion, D., & collaborators of the CNR-MAJ project
- Affiliations
- Inserm (FR)
- Centre Hospitalier Universitaire d'Angers (FR)
- Centre Hospitalier Sainte-Anne (FR)
- Centre National de la Recherche Scientifique (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- CHU Dijon Bourgogne (FR)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Hospices Civils de Lyon (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Corresponding author
- Campion, Dominique
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-03-28
- Volume
- 14
- Issue
- 3
- Pages
- e1002270
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5370101
- OpenAlex
- W2600872530
- Cited by
- 616
- References
- 44
- Citations by year
- 2026: 58 · 2025: 102 · 2024: 94 · 2023: 75 · 2022: 79 · 2021: 64 · 2020: 58 · 2019: 41 · 2018: 34 · 2017: 9
- FWCI
- 28.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, cc-by)
- Funders
- Clinical Research Hospital Program from the French Ministry of Health (GMAJ 2008/067)
- French Ministry of Health (CNR-MAJ)
- European Union (JPND PERADES, ANR-13-JPRF-0001-04)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- early-onset Alzheimer's disease, APP mutations, PSEN1 mutations, PSEN2 mutations, presenilin, amyloid precursor protein, novel mutations, de novo mutations, sporadic Alzheimer's disease, familial Alzheimer's disease, genetic screening, variant interpretation, cerebrospinal fluid biomarkers, total tau, phosphorylated tau, amyloid-beta 42, genetic counseling, mutation carriers
- MeSH terms
- Adult, Alzheimer Disease, Female, France, Genetic Testing, Humans, Male, Middle Aged, Mutation, Amyloid beta-Protein Precursor, Age of Onset, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
